The Business School has an Advisory Board, comprising high-level outside representatives of business. Its current members are:
Iain Conn (Chair), Chief Executive, Centrica
Iain Conn is Chair of the Business School’s Advisory Board. Iain is Chief Executive of Centrica. Before joining Centrica in 2015, he was a member of the BP board of directors and a member of the BP executive management team. He was the Chief Executive of BP Group’s refining and marketing business and also held regional responsibility for Europe, Southern Africa and Asia Pacific.
Iain was born in Edinburgh, educated in Musselburgh, Scotland and subsequently studied Chemical Engineering & Management at Imperial College London. He joined BP Oil International in 1986, working in a variety of roles in commercial refining and oil trading, and in corporate headquarters before moving to BP Exploration in Colombia in 1996. At the end of 1997, he became Senior Vice President of BP Oil in the US, responsible for retail and commercial marketing operations, refining and supply.
On the merger between BP and Amoco in 1999 he moved to become Vice President of BP Amoco Exploration’s mid-continent business unit. At the end of 2000, he returned to London as Group Vice President and a member of the refining and marketing segment’s executive committee, with responsibility for BP’s marketing business in Asia, Russia, Africa and Latin America. In 2001, he took over responsibility for BP’s marketing operations in Europe and for the acquisition and integration of Veba Oel. From 2002 until 2004, he was Chief Executive of BP Petrochemicals and led the strategy to divest BP’s European and US olefins and derivatives activities.
As well as being Chairman of the School’s Advisory Board, Iain is a senior independent director of Rolls-Royce Group.
Zein Abdalla, Former President, PepsiCo
Zein Abdalla was the President of PepsiCo Inc, a leading global food, snack and beverage company, from 2012 through to his retirement in 2014. Prior to that he served as the CEO of PepsiCo Europe. In his 19 years at the company, Zein held a number of senior executive positions across a wide range of diverse businesses and led a number of large-scale acquisitions and transformations for the corporation.
Prior to joining PepsiCo, Zein held a number of senior management positions with the Mars Group, starting as an engineer and progressing across multiple functions before becoming the General Manager of their Middle East and North Africa business. His executive experience with large scale global companies has given him expertise in corporate management, general management, in developed and emerging markets, supply chain, procurement, global brand management, and innovation and global strategy.
Zein received a BSc in Electrical Engineering from Imperial College London. He serves on the Board of Directors of two US public companies: TJX a leading retailer of apparel and home fashions in the US, Canada and Europe; and Cognizant, a global provider of IT, consultancy and business outsourcing services.
Ian Coleman, Chairman, Vixcroft
Ian Coleman is a highly experienced international professional services business builder, and a valuation and strategy specialist. In addition to being Chairman of Vixcroft, a well established property company, he continues to consult privately through Chiddingstone Consulting.
From 1987 to 2012, Ian worked for PricewaterhouseCoopers; his final position at the company was as Senior Chief Relationship Partner. At PwC, Ian managed a number of key client accounts, consulting to senior executives on corporate value issues including financial strategy, transactions, value based management and investor communications. Ian led the development of the firm’s Global Valuation & Strategy practice within its advisory business line from 2000 to 2007 and was Head of Emerging Markets from 2007 to 2009.
He is a frequent speaker on valuation topics with a particular focus on the financial services and energy sectors. Prior to joining PwC Ian worked for eight years at 3i, a leading venture capital firm.
Bronwyn Curtis, Chairman, JP Morgan AIT
Bronwyn Curtis is a financial economist who has held senior executive positions in financial and media organisations. In addition to her position at JP Morgan AIT, Bronwyn is also a Non Executive Director at Scottish American Investment Trust, a Director at Mercator Media and a Governor of the London School of Economics.
From 2008 to 2013, she was Head of Global Research for HSBC. Before joining HSBC, Bronwyn was a partner in Arch Financial Products and served as Chief Economist. From 1999 to 2006, she was Head of European Broadcast at Bloomberg LP, where she was responsible for production and editorial for its 24-hour business and financial news coverage.
Bronwyn has a Masters degree from the London School of Economics, and is an Economics graduate of La Trobe University, Australia. She is a widely published author and a regular speaker on television and radio.
Sunil Kappagoda, advisor and board member, fintech, banking and financial services companies
Sunil Kappagoda has a 27-year track record of delivering high impact results in the financial services sector, with a particular focus on fintech. Sunil’s experience spans the Boston Consulting Group, Oliver Wyman, Booz Allen, Verifone Systems, Citibank and the World Bank.
Most recently, at Verifone Systems, Sunil was President of the Asia Pacific Region and EVP of Corporate Strategy. Prior to that he was a Senior Partner and Managing Director at the Boston Consulting Group, based in the US. He moved back to the US from Singapore in 2016; he is based in Silicon Valley and works as a director/advisor for five to six mid-cap/later stage fintech companies and financial institutions.
Sunil has an undergraduate degree from Imperial College London and postgraduate degrees from Birkbeck College, London School of Economics and the Wharton School, University of Pennsylvania.
Joanne Linder, Owner, SmartPitch
Joanne Linder is the co-chair of Imperial College Business School Alumni Advisory Board and is an active member of the alumni community.
Joanne started her career at BAE Systems, initially on air-borne systems and then in the military aircraft division. She had a largely blue chip career until her MBA, including at Granada and ABN AMRO. She set up her first business upon graduating, having specialised in entrepreneurship, and was a pioneer in personalised web content during the dot-com boom. She runs a portfolio of investments and business interests of her own and assists others to develop their businesses through their growth stages.
Joanne has a BSc in Pure Mathematics from Queen Mary University of London, is an Associate of the Institute of Chartered Secretaries and Administrators and has an MBA with distinction from Imperial College Business School.
Mary Meaney, Senior Partner, McKinsey
Mary Meaney leads McKinsey’s Organisation practice in Europe, the Middle East, and Africa; she was previously the Global People Leader and Global Learning Leader for McKinsey’s Organisation practice and led the research on transformational change. Mary works with a broad range of clients in all sectors on performance and organisational health issues. She primarily advises clients in the consumer-packaged-goods, chemical, and pharmaceutical industries, as well in as the public sector.
Mary is a co-founder of the McKinsey Women’s Initiative, which aims to promote women leaders in business. She regularly participates in McKinsey research evaluating the progress of women in leadership in the corporate world, and recommending means of fostering it.
In addition to her consulting work, Mary is a member of the board of trustees of TeachFirst. Prior to joining McKinsey, she worked at the Center for Strategic and International Studies.
She has a D.Phil from Oxford on a Rhodes Scholarship and a BA from Princeton University.
Catherine Moukheibir, Chairman, MedDay Pharmaceuticals
Catherine Moukheibir is a very experienced finance executive who has held senior positions in big, small, public and private companies. She joined Innate Pharma in 2011 to oversee the company’s corporate and financial strategy.
Prior to joining Innate Pharma, Catherine was CFO of Movetis, a Belgian biotech company (from 2008 to 2010), for which she led the IPO on Euronext Brussels and then the acquisition by Shire. Her prior career included 15 years in senior positions in pharma and biotech and in investment banking.
Catherine is currently Chair at Creabilis (UK) and a NED at Ablynx (Belgium), Zealand Pharma (Denmark), and Cerenis (France).
Michael Shepherd, Managing Director, Growth Point Technology Partners
Mike co-founded Growth Point Technology Partners. He is a software engineer and entrepreneur, who is based in Silicon Valley and now advises technology companies with investments and exits. He has closed transactions with companies such as BMC Software, Cavium, Fair Isaac, HP, IBM, Intel, Microsoft, Oracle, Symantec, F5 and VMware.
Before co-founding GrowthPoint Technology Partners, Mike was a principal at SVB Alliant conducting software mergers and acquisitions transactions. Prior to joining Alliant, he was Managing Director of the Nextera Interactive division of Nextera through to its IPO. At Nextera, he worked with News Corporation on bringing the company’s assets to the internet and with Hilton Hotels, Starwood and Marriott on internet strategy.
Before Nextera, Mike founded and served as President and CEO at Pyramid Imaging, which was sold to Nextera in 1998. Pyramid was a software and services company focused on financial services and utilities. While at Pyramid, he started and spun out two other companies, an interactive entertainment company and a video indexing company. Prior to Pyramid, Mike was a management consultant at Booz Allen & Hamilton and a manager at Accenture in the Advanced Technology Group. Earlier in his career, Mike was one of the earliest members of the team that started The Independent newspaper.
Mike graduated from Imperial College London with a BSc in Biochemistry, and specialized in Biotechnology. He is an Associate of the Royal College of Science. He also graduated from the Stanford Graduate School of Business, and is a Sloan Fellow. Mike currently serves on the board of directors of OM Records.
Rolf Stahel, Chairman, Chesyl Pharma
Rolf registered Chesyl Pharma, which offers consultancy services to portfolio companies, in 2003 and became its chairman. He is also non-executive Chairman of Connexios Life Sciences, Ergomed and Midatech Pharma.
Previously, he was CEO of Shire Pharmaceuticals Group (1994 to 2003) and has held senior roles at Wellcome . As Regional Director at Wellcome , Rolf was responsible for 18 Pacific Rim countries. His last position with the company was Director of Group Marketing, reporting to the Chief Executive.
He received the Chief Executive Officer of the Year 2001 Award for the global pharmaceutical industry from Informa. In 2003 he further received the award for “Most Significant Contribution to UK Lifesciences” from TechMark Mediscience.